CVC Capital Partners, a private equity firm, is reportedly considering strategic options for Finnish healthcare company Mehilainen. The firm has been in talks with potential advisers regarding a potential sale or initial public offering (IPO) of Mehilainen, which could be valued at up to €5 billion.
Mehilainen, which was purchased by a consortium led by CVC in 2018, provides a range of healthcare services including private medical treatment, public healthcare services, and residential care. With over 800 locations across multiple countries including Finland, Estonia, Sweden, and Germany, the company has seen significant growth in revenue, with a 17% increase to €1.63 billion last year.
Founded over a century ago, Mehilainen takes its name from a mythical creature in the Finnish national epic “Kalevala.” The company has become a prominent player in the healthcare sector, offering a wide range of services to meet the needs of individuals in different countries.
While discussions are still in the early stages, the potential sale or IPO of Mehilainen could be a significant move for both CVC and the healthcare company. It remains to be seen whether these deliberations will lead to a concrete deal.
Sources:
– Bloomberg Businessweek
